US$ 28.05
semaglutide not fda approved Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle FDA approves obesity drug that
Description
A 2026 study published in The Lancet Obstetrics, Gynaecology & Womens Health found that combining GLP-1 therapy with HRT produced greater mean weight loss than GLP-1 alone in this patient population

Carefully Sourced and Supervised Medications are prescribed by licensed providers and sourced from PCAB-accredited pharmacies

This remains an area of active research rather than established clinical practice, and until adequately powered, randomised controlled trials assess the safety and efficacy of this specific combination, clinicians and patients should approach any claims about its benefits with appropriate scepticism

Thank you SlideTeam!

You can lose up to 15+ lbs